Related references
Note: Only part of the references are listed.Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines
Gerardo Montalvo Zurbia-Flores et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)
A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage
Frank Gambino et al.
CELL REPORTS (2021)
The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
Kirsten S. Vannice et al.
NPJ VACCINES (2021)
Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
Himanshu Garg et al.
SCIENTIFIC REPORTS (2020)
The continued threat of emerging flaviviruses
Theodore C. Pierson et al.
NATURE MICROBIOLOGY (2020)
Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise
Mareike Kubinski et al.
VACCINES (2020)
Zika virus infection enhances future risk of severe dengue disease
Leah C. Katzelnick et al.
SCIENCE (2020)
Current Flavivirus Research Important for Vaccine Development
Elizabeth Geerling et al.
VACCINES (2020)
Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli
Sergio C. Araujo et al.
VACCINES (2020)
West Nile virus vaccines - current situation and future directions
Sebastian Ulbert
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Twenty Years of Progress Toward West Nile Virus Vaccine Development
Jaclyn A. Kaiser et al.
VIRUSES-BASEL (2019)
Capsid containing virus like particle vaccine against Zika virus made from a stable cell line
Himanshu Garg et al.
VACCINE (2019)
NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice
B. Grubor-Bauk et al.
SCIENCE ADVANCES (2019)
Investigating Tick-borne Flaviviral-like Particles as a Delivery System for Gene Therapy
Anne H. Neddermeyer et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2018)
Diagnostic aptitude of West Nile virus-like particles expressed in insect cells
Belen Rebollo et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Development of a Japanese encephalitis virus genotype V virus-like particle vaccine in silkworms
Kuniaki Nerome et al.
JOURNAL OF GENERAL VIROLOGY (2018)
Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study
Thalia Velho Barreto de Araujo et al.
LANCET INFECTIOUS DISEASES (2018)
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
S. Sridhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice
Ravi Kant Rajpoot et al.
SCIENTIFIC REPORTS (2018)
Genotype I of Japanese Encephalitis Virus Virus-like Particles Elicit Sterilizing Immunity against Genotype I and III Viral Challenge in Swine
Yi-Chin Fan et al.
SCIENTIFIC REPORTS (2018)
Zika virus like particles elicit protective antibodies in mice
Mauricio A. Salvo et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
Rahul Shukla et al.
FRONTIERS IN MICROBIOLOGY (2018)
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Shiyu Dai et al.
VIROLOGICA SINICA (2018)
Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach
Chao Shan et al.
JOURNAL OF VIROLOGY (2018)
A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled Infection Rounds that Protects against Vertical Transmission
Xuping Xie et al.
CELL HOST & MICROBE (2018)
Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice
Angela M. Fowler et al.
CELL HOST & MICROBE (2018)
High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon
Mami Matsuda et al.
SCIENTIFIC REPORTS (2018)
Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris Are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies
Niyati Khetarpal et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Utility of Japanese encephalitis virus subgenomic replicon-based single-round infectious particles as antigens in neutralization tests for Zika virus and three other flaviviruses
Atsushi Yamanaka et al.
JOURNAL OF VIROLOGICAL METHODS (2017)
Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus
Himanshu Garg et al.
JOURNAL OF VIROLOGY (2017)
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design
Akane Urakami et al.
JOURNAL OF VIROLOGY (2017)
Achieving safe, effective, and durable Zika virus vaccines: lessons from dengue
Scott B. Halstead
LANCET INFECTIOUS DISEASES (2017)
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
Susana V. Bardina et al.
SCIENCE (2017)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Single-Round Infectious Particle Antiviral Screening Assays for the Japanese Encephalitis Virus
Chien-Yi Lu et al.
VIRUSES-BASEL (2017)
Zika virus-like particle (VLP) based vaccine
Helene Boigard et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day
Natalie D. Collins et al.
CURRENT INFECTIOUS DISEASE REPORTS (2017)
Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques
Jeffy George et al.
SCIENTIFIC REPORTS (2017)
Development of a Japanese encephalitis virus-like particle vaccine in silkworms using codon-optimised prM and envelope genes
Sayaka Matsuda et al.
HELIYON (2017)
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
Ankur Poddar et al.
BMC BIOTECHNOLOGY (2016)
Human T cell responses to Japanese encephalitis virus in health and disease
Lance Turtle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys
Lazaro Gil et al.
JOURNAL OF IMMUNOLOGY (2016)
The Brazilian Zika virus strain causes birth defects in experimental models
Fernanda R. Cugola et al.
NATURE (2016)
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
Wanwisa Dejnirattisai et al.
NATURE IMMUNOLOGY (2016)
The 3.8 Å resolution cryo-EM structure of Zika virus
Devika Sirohi et al.
SCIENCE (2016)
Yellow fever vaccine-associated viscerotropic disease: current perspectives
Roger E. Thomas
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells
Amporn Suphatrakul et al.
VACCINE (2015)
Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
Lav Tripathi et al.
FRONTIERS IN MICROBIOLOGY (2015)
Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management
Petra Bogovic et al.
WORLD JOURNAL OF CLINICAL CASES (2015)
Japanese encephalitis virus replicon-based vaccine expressing enterovirus-71 epitope confers dual protection from lethal challenges
Yi-Ting Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Production of single-round infectious chimeric flaviviruses with DNA-based Japanese encephalitis virus replicon
Ryosuke Suzuki et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus
Carlo Amorin Daep et al.
JOURNAL OF NEUROVIROLOGY (2014)
An optimized expression vector for improving the yield of dengue virus-like particles from transfected insect cells
Nicha Charoensri et al.
JOURNAL OF VIROLOGICAL METHODS (2014)
Protection of a Single Dose West Nile Virus Recombinant Subviral Particle Vaccine against Lineage 1 or 2 Strains and Analysis of the Cross-Reactivity with Usutu Virus
Teresa Merino-Ramos et al.
PLOS ONE (2014)
Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil
Reinaldo de Menezes Martins et al.
VACCINE (2014)
Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays
Atsushi Yamanaka et al.
VACCINE (2014)
Toward Animal Cell Culture-Based Influenza Vaccine Design: Viral Hemagglutinin N-Glycosylation Markedly Impacts Immunogenicity
Julia Huetter et al.
JOURNAL OF IMMUNOLOGY (2013)
Differential Targeting of Viral Components by CD4+ versus CD8+ T Lymphocytes in Dengue Virus Infection
Laura Rivino et al.
JOURNAL OF VIROLOGY (2013)
Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
Shailendra Mani et al.
PLOS ONE (2013)
Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010
J. G. Breugelmans et al.
VACCINE (2013)
Production of Japanese encephalitis virus-like particles in insect cells
Hideki Yamaji et al.
BIOENGINEERED (2013)
N-glycosylation of the premembrane protein of Japanese encephalitis virus is critical for folding of the envelope protein and assembly of virus-like particles
J. Zai et al.
ACTA VIROLOGICA (2013)
Production of Japanese encephalitis virus-like particles using the baculovirus-insect cell system
Hideki Yamaji et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2012)
Replicon-based Japanese encephalitis virus vaccines elicit immune response in mice
Ying Huang et al.
JOURNAL OF VIROLOGICAL METHODS (2012)
Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres
Pavel Plevka et al.
EMBO REPORTS (2011)
Characterization of the RepliVax platform for replication-defective flavivirus vaccines
Alexander A. Rumyantsev et al.
VACCINE (2011)
From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
Bruno Guy et al.
VACCINE (2011)
Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
Shuo Zhang et al.
VIROLOGY JOURNAL (2011)
Flavivirus Cell Entry and Membrane Fusion
Jolanda M. Smit et al.
VIRUSES-BASEL (2011)
Evaluation of Extracellular Subviral Particles of Dengue Virus Type 2 and Japanese Encephalitis Virus Produced by Spodoptera frugiperda Cells for Use as Vaccine and Diagnostic Antigens
Miwa Kuwahara et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate
Naohiro Ohtaki et al.
VACCINE (2010)
Efficient, trans-complementing packaging systems for chimeric, pseudoinfectious dengue 2/yellow fever viruses
Alexandr V. Shustov et al.
VIROLOGY (2010)
Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice
Lazaro Gil et al.
INTERNATIONAL IMMUNOLOGY (2009)
Expert Opinion on Vaccination of Travelers Against Japanese Encephalitis
Gerd D. Burchard et al.
JOURNAL OF TRAVEL MEDICINE (2009)
Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2
Ryosuke Suzuki et al.
JOURNAL OF VIROLOGY (2009)
Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus
Hidehiro Takahashi et al.
MICROBES AND INFECTION (2009)
Construction and application of chimeric virus-like particles of tick-borne encephalitis virus and mosquito-borne Japanese encephalitis virus
Kentaro Yoshii et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis
Tomohiro Ishikawa et al.
VACCINE (2008)
Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system
Douglas G. Widman et al.
VACCINE (2008)
A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles
Szu-Chia Hsieh et al.
VIROLOGY (2008)
Production of pseudoinfectious yellow fever virus with a two-component genome
Alexandr V. Shustov et al.
JOURNAL OF VIROLOGY (2007)
Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases
Ann W. McMahon et al.
VACCINE (2007)
Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line
Fuquan Zhang et al.
VIROLOGY JOURNAL (2007)
Production and characterization of vaccines based on flaviviruses defective in replication
Peter W. Mason et al.
VIROLOGY (2006)
Packaging the replicon RNA of the Far-Eastern subtype of tick-borne encephalitis virus into single-round infectious particles: development of a heterologous gene delivery system
K Yoshii et al.
VACCINE (2005)
Induction of sterilizing immunity against west nile virus (WNV), by immunization with WNV-like particles produced in insect cells
M Qiao et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line
R Gehrke et al.
JOURNAL OF VIROLOGY (2003)
Structures of immature flavivirus particles
Y Zhang et al.
EMBO JOURNAL (2003)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)
Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: Identification of HLA-1335-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E
MDT Co et al.
VIROLOGY (2002)
Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine
E Konishi et al.
VACCINE (2002)
Molecular organization of a recombinant subviral particle from tick-borne encephalitis
I Ferlenghi et al.
MOLECULAR CELL (2001)
Share Paper
